US Patent Issued to AstraZeneca on March 24 for "PCSK9 inhibitors and methods of use thereof" (Massachusetts, Ohio Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,120, issued on March 24, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"PCSK9 inhibitors and methods of use thereof" was invented by Michael H. Serrano-Wu (Belmont, Mass.), Brian K. Hubbard (Boxford, Mass.), Virendar Kaushik (Bedford, Mass.) and Doug Daniels (Oakwood, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that bind the PCSK9 protein."

The patent was filed on Jan. 25, 2023, under Application No. 18/159,270.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Se...